ARMISTICE CAPITAL LLC 13D/13G Filings for Aptevo Therapeutics Inc. (APVO)

ARMISTICE CAPITAL LLC 13D and 13G filings for Aptevo Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
3:24 pm
Purchase
2023-12-3113GAPTEVO THERAPEUTICS INC NE
APVO
ARMISTICE CAPITAL LLC3
9.990%
3increase
(New Position)
Filing